UC
unexpected cases
We report the results of a seven-month prospective cohort study investigating COVID-19 patients to assess unexpected cases (UC) (no COVID-19 precautionary measure application since admission) and NC.
Crohn's disease (CD) and ulcerative colitis (UC) are two types of chronic IBD.
ETHNOPHARMACOLOGICAL RELEVANCE Ulcerative colitis (UC) is a major cause of morbidity and mortality due to repetitive remissions and relapses, and many severe complications, including colitis-associated cancer (CAC).
Ulcerative colitis (UC) is a disease characterized by chronic inflammation of the colon.
Background and Aim The number of patients with ulcerative colitis (UC) has been increasing in Japan.
Endoscopic mucosal healing (MH) is an important treatment goal for patients with ulcerative colitis (UC).
We divided the IBD group into ulcerative colitis (UC) and Crohn's disease (CD) subgroups and compared each with the non-IBD group.
OBJECTIVE To elucidate the protective effect of Qingdai (, QD) on ulcerative colitis (UC) by means of and approaches.
IBD subtypes were classified as ulcerative colitis (UC), Crohn's disease (CD) or unclassified IBD (IBD-U).
Ulcerative colitis (UC) is a chronic non-specific inflammatory disease of the intestine, which is prone to recurrence and difficult to cure.
pH-Responsive nanotherapeutics were recently developed for the treatment of ulcerative colitis (UC).
Each 5 urothelial carcinoma (UC) cell lines with and without the v-Raf murine sarcoma virus oncogene homolog B (BRAF) gene mutation (V595E) were established and examined V595E-related tumorigenic characteristics in dogs.
Residents requiring a continence assessment or reassessment in an NH with 2 units assigned to intervention (I) and 2 units to usual care (UC).